%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-07-27T13:54:55+03:00
2013-07-27T13:54:54+03:00
2013-07-27T13:54:55+03:00
application/pdf
bs-1165R-Biotin
uuid:922325f7-e741-4de0-9ae2-cc8fc2ffab94
uuid:070bccd1-cd81-4c64-bb52-8840a4ccc379
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[39 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.632 574.5 -722.507 re
f
BT
0.2 scn
/TT0 1 Tf
6.4915 0 0 6.4915 21.0356 768.2441 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw T*
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
138.2694855 0 0 -77.8983002 446.2304993 810.4389801 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.0881 0 0 9.0881 21.0356 717.6102 Tm
[(bs)-67(-)-69(1165R)-12(-)-69(Biotin)]TJ
/TT0 1 Tf
-0.04 Tw 7.1407 0 0 7.1407 22.3339 672.1695 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(This)-1( gene)-19( encodes)-23( not)-20( only)-81( an)-8( important)-88( cytoplasmic)-63( component)-84( of)-48( the)-36( classical)-85( cadherin)-48( adhesion)-62( complex)-80( that)]TJ
T*
[(forms)-38( the)-36( adherens)-39( junction)-22( in)-31( epithelia)-18( and mediates)-21( cell)-9(-)-1(cell)-9( adhesion)-62( in)-31( many)-34( other)-43( tissues)-15( but)-9( also)-75( a)-20( key)]TJ
0 -1.455 TD
[(signaling)-29( molecule)-88( in)-31( the)-37( canonical)-2( Wnt)-24( signaling)-29( pathway)-83( that)-67( controls)-71( cell)-9( growth)-1( and differentiation)-42( during)]TJ
T*
[(both)-12( normal)-36( development)-41( and tumorigenesis.)-4( The)-59( gene)-19( product)-2( contains)-73( a)-20( central)-7( armadillo)-58(-)-1(repeat)-85( containing)]TJ
T*
[(domain)-25( through)-81( which)-88( it)-73( binds)-25( the)-36( cytoplasmic)-63( tail)-47( of)-48( classical)-85( cadherins;)-66( meanwhile,)-55( it)-73( also)-75( binds)-25( alpha)-64(-)-1(catenin,)]TJ
0 -1.455 TD
[(which)-88( further)-77( links)-40( the)-37( cadherin)-48( complex)-80( to)-32( the)-37( actin)-75( cytoskeleton)-49( either)-12( directly)-83( or)-6( indirectly.)-84( Beta)-26(-)-1(catenin)-82( is)]TJ
0 -1.455 TD
[(therefore)-40( necessary)-18( for)-52( the)-37( adhesive)-48( function)-77( of)-48( classical)-85( cadherins.)-26( Another)-66( key)-23( function)-77( of)-48( this)-69( protein)-79( is)-52( to)]TJ
T*
[(mediate)-12( the)-36( canonical)-2( Wnt)-24( signaling)-29( pathway)-83( and regulate)-25( gene)-19( transcription.)-25( Without)-87( Wnt)-24( signal,)-66( cytoplasmic)]TJ
0 -1.455 TD
[(beta)-62(-)-1(catenin)-82( that)-67( is)-52( not)-19( associated)-48( with)-46( the)-36( cadherin)-48( complex)-80( is)-52( quickly)-65( phosphorylated)-39( at)-50( the)-36( N)-60(-)-1(terminal)]TJ
0 -1.455 TD
[(Ser/Thr)-37( residues)-83( by)-40( the)-36( so)-11( called)-22( degradation)-14( complex)-80( containing)-88( axin,)-72( adenomatous)-49( polyposis)-51( coli)-83( \(APC\),)-88( casein)]TJ
0 -1.455 TD
[(kinase)-36( I,)-51( and GSK3B,)-23( then)-24( ubiquitylated)-48( by)-40( beta)-62(-)-1(TrCP,)-56( and degraded)-33( by)-40( the)-36( proteasome.)-46( However,)-9( in)-31( the)]TJ
0 -1.455 TD
[(presence)-44( of)-48( Wnt)-24( signal,)-66( the)-36( degradation)-14( complex)-80( is)-52( disrupted)-70( and the)-36( stabilized)-23( cytoplasmic)-63( beta)-62(-)-1(catenin)]TJ
0 -1.455 TD
[(translocates)-77( into)-63( the)-36( nucleus,)-88( where)-15( it)-73( binds)-25( various)-23( transcription)-55( factors)-13( and,)-61( together)-84( with)-46( these)-65( factors,)]TJ
0 -1.455 TD
[(regulates)-34( the)-37( transcription)-55( of)-48( many)-33( downstream)-27( genes.)-88( Mutations)-66( of)-48( this)-69( gene)-19( have)-75( been)-19( linked)-43( with)-46( various)]TJ
0 -1.455 TD
[(types)-7( of)-48( tumors.)-70( Alternatively)-9( spliced)-3( variants)-70( have)-75( been)-19( found)-15( for)-52( this)-69( gene.)-79( [provided)-75( by)-40( RefSeq].)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Prepared)-46( as)-29( lyophilized)-45( powder)-87( and shipped)-36( on)-81( ice.)-26( Store)-44( at)-50( -)-1(20\260C)-18( for)-52( one)-9( year)-91( as)-29( lyophilized)-45( powder)-87( or)-6( liquid.)]TJ
0 -1.455 TD
[(Please)-15( reconstitute)-64( before)-83( use.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-37( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-36( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-37( package.)]TJ
/TT1 1 Tf
0 Tw 53.546 41.455 Td
(Size:)Tj
/TT0 1 Tf
-0.04 Tw 3 -0.091 Td
[(100ul)-29( or)-6( 100ug)-69( lyophilized)]TJ
/TT1 1 Tf
0 Tw -3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.4915 0 0 6.4915 404.6847 627.378 Tm
(Human,Mouse,Rat,Chicken,Pig,Cow,Rabbit,Zebrafish,Sheep,)Tj
0 scn
/TT1 1 Tf
7.1407 0 0 7.1407 404.6847 613.7458 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 414.422 596.5432 cm
0 0 m
0 1.298 -1.947 1.298 -1.947 0 c
-1.947 -1.298 0 -1.298 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.1407 0 0 7.1407 420.9135 594.9203 Tm
[(WB\(1:100)-43(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 414.422 586.1567 cm
0 0 m
0 1.298 -1.947 1.298 -1.947 0 c
-1.947 -1.298 0 -1.298 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.1407 0 0 7.1407 420.9135 584.5339 Tm
[(ELISA\(1:500)-35(-)-1(1000\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 414.422 575.7704 cm
0 0 m
0 1.298 -1.947 1.298 -1.947 0 c
-1.947 -1.298 0 -1.298 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.1407 0 0 7.1407 420.9135 574.1475 Tm
[(IHC)-78(-)-1(P\(1:100)-73(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 414.422 565.3839 cm
0 0 m
0 1.298 -1.947 1.298 -1.947 0 c
-1.947 -1.298 0 -1.298 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.1407 0 0 7.1407 420.9135 563.761 Tm
[(IHC)-78(-)-1(F\(1:100)-13(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 414.422 554.9974 cm
0 0 m
0 1.298 -1.947 1.298 -1.947 0 c
-1.947 -1.298 0 -1.298 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.1407 0 0 7.1407 420.9135 553.3746 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)-57( Optimal)]TJ
0 -1.455 TD
[(working)-62( dilutions)-48( must)-4( be)-12( determined)-86( by)-40( the)-37( end)]TJ
0 Tw 0 -1.455 TD
(user.)Tj
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.4915 0 0 6.4915 446.8796 491.0559 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.1407 0 0 7.1407 404.6847 477.4237 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.4915 0 0 6.4915 481.9339 477.4237 Tm
(92kDa)Tj
0 scn
/TT1 1 Tf
7.1407 0 0 7.1407 404.6847 463.7915 Tm
(Preservatives:)Tj
0.2 scn
/TT0 1 Tf
-0.012 Tw 6.4915 0 0 6.4915 467.6525 463.7915 Tm
[(10ug/uL)-59( )1(BSA)-54( )1(and)-64( )1(0.1%)-28( )1(NaN3.)]TJ
0 scn
0.021 Tw 5.8424 0 0 5.8424 404.6847 437.1763 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)-97( )1(animal)]TJ
0 -1.333 TD
[(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
551.7796173 0 0 -0.6491547 23.6322021 709.1711884 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.3864 0 0 10.3864 15.1932 95.0729 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 13.2458 694.2407 cm
0 0 m
0 1.731 -2.597 1.731 -2.597 0 c
-2.597 -1.731 0 -1.731 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/C2_0 1 Tf
9.0881 0 0 9.0881 22.3339 691.644 Tm
[<0035004400450045004C0057>-50<0003>7<002400510057004C>-28<0010>-69<01C3>-2<0010>-69<00460044005700480051004C0051001200260044005700480051004C0051>-61<0003>7<01C3>-2<0003>7<00330052004F005C0046004F005200510044004F>-4<0003>7<002400510057004C004500520047005C000F>-47<0003>7<0025004C00520057004C0051>-37<0003>7<004600520051004D0058004A0044005700480047>]TJ
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 19.0881348 380.7000122 cm
/Im2 Do
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
10.3864 0 0 10.3864 19.0881 298.2576 Tm
( )Tj
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 143.7254181 380.7000122 cm
/Im3 Do
Q
BT
/TT0 1 Tf
10.3864 0 0 10.3864 143.7254 298.2576 Tm
( )Tj
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 268.3627014 380.7000122 cm
/Im4 Do
Q
BT
/TT0 1 Tf
10.3864 0 0 10.3864 268.3627 298.2576 Tm
( )Tj
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 19.0881348 295.0118713 cm
/Im5 Do
Q
BT
/TT0 1 Tf
10.3864 0 0 10.3864 19.0881 212.5695 Tm
( )Tj
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 143.7254181 295.0118713 cm
/Im6 Do
Q
BT
/TT0 1 Tf
10.3864 0 0 10.3864 143.7254 212.5695 Tm
( )Tj
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 268.3627014 295.0118713 cm
/Im7 Do
Q
BT
/TT0 1 Tf
10.3864 0 0 10.3864 268.3627 212.5695 Tm
( )Tj
ET
q
/GS0 gs
97.372879 0 0 -73.3542328 19.0881348 209.3237457 cm
/Im8 Do
Q
BT
/TT0 1 Tf
10.3864 0 0 10.3864 19.0881 126.8814 Tm
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-0.04 Tw 7.1407 0 0 7.1407 20.3864 95.7221 Tm
[(For)-31( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.4915 0 0 6.4915 170.9898 95.7221 Tm
(HERE)Tj
/CS0 cs 0 scn
7.1407 0 0 7.1407 187.2186 95.7221 Tm
(.)Tj
ET
q
/GS0 gs
0.6491547 0 0 -584.2372437 392.3508301 708.5220184 cm
/Im9 Do
Q
q
/GS0 gs
5.8423767 0 0 -39.5982971 578.657608 132.7237549 cm
/Im10 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(#/+o)
endobj
28 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L